| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.18 | 0.6 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | 0.1 | 0.6 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.031 | 0.6 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |